Literature DB >> 24659164

The persian version of the chronic urticaria quality of life questionnaire: factor analysis, validation, and initial clinical findings.

Marzieh Tavakol1, Payam Mohammadinejad2, Ilaria Baiardini3, Fulvio Braido3, Mohammad Gharagozlou4, Asghar Aghamohammadi5, Mohammad Nabavi6, Abbas Dabbaghzade4, Zahra Tavakol7, Mohsen Afarideh2, Nima Rezaei8.   

Abstract

Chronic urticaria (CU) also known as chronic idiopathic urticaria results in a lowered quality of life (QoL). Disease specific questionnaires are necessary to assess QoL in CU patients. Chronic Urticaria Quality of Life Questionnaire (CU-Q2oL) is the only available and validated disease specific questionnaire in the assessment of QoL in CU patients originally developed in Italian language. The aim of the current study was to develop the Persian version of the CU-Q2oL with an acceptable reliability and validity.Using the standard methods provided by guidelines, CU-Q2oL was translated into Persian. A total number of 110 patients with confirmed diagnosis of CU were asked to fill the questionnaire. Determination of scales was performed in addition to checking the data for internal consistency and known group validity. Urticaria activity score 7 (UAS7) was used to assess the severity of the CU in the population study. The 6 dimensional scale of Persian CU-Q2oL was determined using the Exploratory Factor Analysis. About 68% of the variance was explained by these 6 factor structure higher than 59.9% of the original Italian version.All 6 factors showed acceptable internal consistency as measured by Cronbach α coefficient. There was a significant correlation between UAS7 and total CU-Q2oL score. UAS7 and the presence of angioedema were predictors of CU-Q2oL score.The Persian version of CU-Q2oL was shown to be a valid and reliable tool to be used in the future clinical studies. Cultural considerations must be kept in mind in adoption of CU-Q2oL to other languages.

Entities:  

Mesh:

Year:  2014        PMID: 24659164

Source DB:  PubMed          Journal:  Iran J Allergy Asthma Immunol        ISSN: 1735-1502            Impact factor:   1.464


  4 in total

Review 1.  Urticaria: Collegium Internationale Allergologicum (CIA) Update 2020.

Authors:  Marcus Maurer; Kilian Eyerich; Stefanie Eyerich; Marta Ferrer; Jan Gutermuth; Karin Hartmann; Thilo Jakob; Alexander Kapp; Pavel Kolkhir; Désirée Larenas-Linnemann; Hae-Sim Park; Gunnar Pejler; Mario Sánchez-Borges; Knut Schäkel; Dagmar Simon; Hans-Uwe Simon; Karsten Weller; Torsten Zuberbier; Martin Metz
Journal:  Int Arch Allergy Immunol       Date:  2020-03-30       Impact factor: 2.749

2.  Impact of chronic urticaria on the quality of life of patients followed up at a university hospital.

Authors:  Gabriela Andrade Coelho Dias; Gisele Viana Pires; Solange Oliveira Rodrigues do Valle; Sérgio Duarte Dortas; Soloni Levy; Alfeu Tavares França; Ilaria Baiardini; Walter Giorgio Canonica
Journal:  An Bras Dermatol       Date:  2016 Nov-Dec       Impact factor: 1.896

3.  Development and Preliminary Validation of the Questionnaire (the First Edition) Based on TCM for Detecting Health Status in China.

Authors:  Xuan Zhou; Fang Xu; Jian Gao; Shan Cao; Ziwei Zhao; Mingli Heng; Huaien Bu; Liqun Yin; Hongwu Wang
Journal:  Evid Based Complement Alternat Med       Date:  2015-10-11       Impact factor: 2.629

4.  Psychometric properties of the portuguese version of the chronic urticaria quality of life questionnaire (CU-Q2oL).

Authors:  Pedro Lopes Ferreira; Margarida Gonçalo; José Alberto Ferreira; Ana Célia Costa; Ana Todo-Bom; Cristina Lopes Abreu; Ana Rita Travassos; Pedro Andrade; Ilaria Baiardini; Giorgio Walter Canonica
Journal:  Health Qual Life Outcomes       Date:  2019-12-30       Impact factor: 3.186

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.